Literature DB >> 19819673

Unsuspected intraoperative finding of structural abnormalities associated with vocal fold polyps.

Claudia Alessandra Eckley1, Marco Antonio Corvo, Rodrigo Yoshimi, João Swensson, André de Campos Duprat.   

Abstract

OBJECTIVES: To report the findings of unsuspected underlying concurrent abnormalities of the vocal fold (VF) associated with polyps. STUDY DESIGN AND
SETTING: Retrospective chart review at tertiary teaching institution. SUBJECTS AND METHODS: Operative and clinical notes of 81 adults submitted to suspension laryngoscopy for vocal fold polyp (VFP) excision from 1998 to 2007, which had no previous report of associated structural abnormalities.
RESULTS: Associated lesions were described in 54 patients (67%) (35 contralateral, 16 ipsilateral, and three bilateral): 18 reactive nodules, 21 sulcus vocalis, five cysts, two microwebs, and eight capillary ectasias. A positive correlation was found between the presence of polyps and associated structural abnormalities (r=0.0035; P<0.05).
CONCLUSIONS: The high incidence of concurrent previously unsuspected VF lesions suggests that either these minor underlying anatomical deviations render the VF more vulnerable to vocal abuse, or that phonotrauma may cause a number of VF lesions that can lead to dysphonia. 2010 The Voice Foundation. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19819673     DOI: 10.1016/j.jvoice.2009.02.001

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  2 in total

1.  Videolaryngostroboscopy versus microlaryngoscopy for the diagnosis of benign vocal cord lesions: a prospective clinical study.

Authors:  Sevtap Akbulut; Hande Altintas; Haldun Oguz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-18       Impact factor: 2.503

2.  The association of sulcus vocalis and benign vocal cord lesions: intraoperative findings.

Authors:  Ahmet Volkan Sünter; Tolga Kırgezen; Özgür Yiğit; Mustafa Çakır
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-31       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.